# P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/p2y12-inhibitor-clopidogrel-inhibits-renal-fibrosis-by-blocking-macrophage-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Junzhe Chen,Ying Tang,Yu Zhong,Biao Wei,Xiao‐Ru Huang,Patrick Ming‐Kuen Tang,Anping Xu,Hui-yao Lan |
| Citations | 99 |
| DOI | 10.1016/j.ymthe.2022.06.019 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/9481993 |
| OpenAlex ID | https://openalex.org/W4283818633 |
| PMID | 35791881 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Yu Zhong](https://scholariq.org/researchers/yu-zhong/)

## Paper primary topic

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Paper topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Abdominal vascular conditions and treatments](https://scholariq.org/topics/abdominal-vascular-conditions-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.